These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9292038)

  • 21. Neuropsychiatric manifestations of systemic lupus erythematosus: diagnosis, clinical spectrum, and relationship to other features of the disease.
    Feinglass EJ; Arnett FC; Dorsch CA; Zizic TM; Stevens MB
    Medicine (Baltimore); 1976 Jul; 55(4):323-39. PubMed ID: 781466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autoantibodies to nervous system tissue in human and murine systemic lupus erythematosus.
    Moore PM
    Ann N Y Acad Sci; 1997 Aug; 823():289-99. PubMed ID: 9292056
    [No Abstract]   [Full Text] [Related]  

  • 23. Neuropsychiatric lupus: a case for guarded optimism.
    Boumpas DT; Scott DE; Balow JE
    J Rheumatol; 1993 Oct; 20(10):1641-3. PubMed ID: 8295171
    [No Abstract]   [Full Text] [Related]  

  • 24. [Neuropsychological signs in lupus].
    Purice S; Damşa T
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1980; 32(2):155-9. PubMed ID: 6107978
    [No Abstract]   [Full Text] [Related]  

  • 25. Chronic ascites in late onset systemic lupus erythematosus with antiphospholipid antibodies.
    Corbella X; Mitjavila F; Campoy E; Saez A; Moga I; Vidaller A
    J Rheumatol; 1994 Jun; 21(6):1141-3. PubMed ID: 7932430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibodies to triosephosphate isomerase in patients with neuropsychiatric lupus.
    Watanabe H; Seino T; Sato Y
    Biochem Biophys Res Commun; 2004 Sep; 321(4):949-53. PubMed ID: 15358119
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cutaneous necrosis resulting from protein S deficiency and increased antiphospholipid antibody in a patient with systemic lupus erythematosus.
    Amster MS; Conway J; Zeid M; Pincus S
    J Am Acad Dermatol; 1993 Nov; 29(5 Pt 2):853-7. PubMed ID: 8408826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The neuropsychiatric disorder in systemic lupus erythematosus: evidence for both vascular and immune mechanisms.
    Bresnihan B; Hohmeister R; Cutting J; Travers RL; Waldburger M; Black C; Jones T; Hughes GR
    Ann Rheum Dis; 1979 Aug; 38(4):301-6. PubMed ID: 496443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myocardial infarction as the presenting manifestation of systemic lupus erythematosus with antiphosphatidylserine antibodies.
    Jansen NL; Snell JR; Moy JN
    Ann Allergy Asthma Immunol; 1996 Mar; 76(3):266-8. PubMed ID: 8634882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuropsychiatric systemic lupus erythematosus. Stress, stroke, and seizures.
    Moore PM
    Ann N Y Acad Sci; 1997 Aug; 823():1-17. PubMed ID: 9292030
    [No Abstract]   [Full Text] [Related]  

  • 31. Systemic lupus erythematosus presenting as pseudocyesis.
    Hernández Rodríguez I; Moreno MJ; Morano LE; Benavente JL
    Br J Rheumatol; 1994 Apr; 33(4):400-2. PubMed ID: 7908846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heart valve disease in systemic lupus erythematosus. Role of antiphospholipid antibodies.
    Meyer O; Golstein M; Nicaise P; Labarre C; Kahn MF
    Clin Rev Allergy Immunol; 1995; 13(1):49-56. PubMed ID: 7648348
    [No Abstract]   [Full Text] [Related]  

  • 33. [Antiphospholipid antibodies and antiphospholipid syndrome in juvenile lupus erythematosus].
    Romicka AM; Gazda A; Zabek J; Wojciechowska B
    Pol Arch Med Wewn; 2006 May; 115(5):477-80. PubMed ID: 17195365
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies.
    Cabiedes J; Cabral AR; Alarcón-Segovia D
    J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurological manifestations of systemic lupus erythematosus: role of antiphospholipid antibodies.
    Golstein M; Meyer O; Bourgeois P; Palazzo E; Nicaise P; Labarre C; Kahn MF
    Clin Exp Rheumatol; 1993; 11(4):373-9. PubMed ID: 8403581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Involuntary movement disorders as first manifestation of systemic lupus erythematosus: case report].
    Kakehasi AM; Bomtempo CA; Vassalo S; Pimenta RC; Carvalho MA; Cardoso F
    Arq Neuropsiquiatr; 2001 Sep; 59(3-A):609-12. PubMed ID: 11588646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiac valvular disease in scleroderma and systemic lupus erythematosus/scleroderma overlap associated with antiphospholipid antibodies.
    Penmetcha M; Rosenbush SW; Harris CA
    J Rheumatol; 1996 Dec; 23(12):2171-4. PubMed ID: 8970061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus.
    İlgen U; Yayla ME; Ateş A; Okatan İE; Yurteri EU; Torgutalp M; Keleşoğlu ABD; Turgay TM; Kınıklı G
    Lupus; 2018 Apr; 27(4):665-669. PubMed ID: 29050535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Multiple osseous avascular necrosis in a patient with systemic lupus erythematosus with antiphospholipid antibody positivity].
    Biasi D; Caramaschi P; Pacor ML; Carletto A; Melchiori S; Manzo T; Bambara LM
    Recenti Prog Med; 1995 Nov; 86(11):449-50. PubMed ID: 8539478
    [No Abstract]   [Full Text] [Related]  

  • 40. Anti-P antibodies and neuropsychiatric lupus erythematosus.
    Georgescu L; Mevorach D; Arnett FC; Reveille JD; Elkon KB
    Ann N Y Acad Sci; 1997 Aug; 823():263-9. PubMed ID: 9292053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.